欧洲移植领域的比利时共识指南 关于高敏感性患者用伊米利菲达酶进行的已故捐赠者的脏移植
Dirk R J Kuypers1,2, Frans H J Claas3,4, Antoine Bouquegneau5
1Department of Nephrology and Renal Transplantation, University Hospitals Leuven, Belgium.
Transplantation
|May 5, 2025
概括
高度敏感的移植候选人面临着接受器官的挑战. 新的imlifidase脱敏指南旨在改善这些患者在欧洲移植网络中的获取.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 移植 移植 移植 移植
背景情况:
- 高度敏感 (HS) 移植候选人 (KTx) (>85%的面板反应性抗体) 的器官获取有限.
- 欧洲移植可接受不匹配 (AM) 计划优先考虑HS患者,但有些人仍然没有移植.
- 开发了一种涉及长期AM患者的伊米利菲达斯脱敏化策略.
研究的目的:
- 描述在HS KTx候选人中对imlifidase脱敏化的共识指南.
- 为欧洲移植网络提供一个可适应临床实践的模型.
- 为了使伊米利菲达斯治疗与欧洲移植分配规则和移植后护理保持一致.
主要方法:
- 由比利时Imlifidase科学专家组制定共识指南.
- 包括患者适应伊米利菲达斯治疗的资格标准.
- 纳入HS患者的移植后管理策略.
主要成果:
- 在HS KTx候选者中建立了对imlifidase脱敏化的共识指南.
- 这些指导方针涉及资格,治疗和移植后管理.
- 这些指导方针是欧洲移植中心的典范.
结论:
- 开发的指导方针为HS KTx候选者的伊米利菲达斯脱敏化提供了一个框架.
- 这些指导方针旨在改善高度敏感的患者获得器官的机会.
- 这些指导方针是动态的,并将根据不断变化的欧洲移植规则和imlifidase经验进行更新.
相关概念视频
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...